Effectiveness and Safety of Delgocitinib Cream in Pustulosis Palmoplantaris: A Case Series
DOI:
https://doi.org/10.2340/actadv.v105.44511Keywords:
Psoriasis, Pustolosis palmoplantaris, palmoplantar, JAK inhibitorDownloads
References
Misiak-Galazka M, Zozula J, Rudnicka L. Palmoplantar pustulosis: recent advances in etiopathogenesis and emerging treatments. Am J Clin Dermatol 2020; 21: 355–370. DOI: https://doi.org/10.1007/s40257-020-00503-5
Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, Köks S, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol 2017; 31: 1792–1799. DOI: https://doi.org/10.1111/jdv.14386
Heidemeyer K, May Lee M, Cazzaniga S, Yawalkar N, Naldi L. Palmoplantar pustulosis: a systematic review of risk factors and therapies. Psoriasis 2023; 13: 33–58. DOI: https://doi.org/10.2147/PTT.S400402
Xu Q, Wang X, Yang A, Wei G. Refractory palmoplantar pustulosis successfully treated with JAK inhibitor tofacitinib: a case series. Infect Drug Resist 2023; 16: 5165–5172. DOI: https://doi.org/10.2147/IDR.S421299
Du N, Yang J, Zhang Y, Lv X, Cao L, Min W. Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patients. Front Med 2024; 11: 1476793. DOI: https://doi.org/10.3389/fmed.2024.1476793
Rahbar Kooybaran N, Tsianakas A, Assaf K, Mohr J, Wilsmann-Theis D, Mössner R. Response of palmoplantar pustulosis to upadacitinib: a case series of five patients. J Dtsch Dermatol Ges 2023; 21: 1387–1392. DOI: https://doi.org/10.1111/ddg.15176
Gleeson D, Barker JN, Capon F, Pink AE, Woolf RT, Smith CH, et al. Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic. Br J Dermatol 2023; 188: 471–473. DOI: https://doi.org/10.1093/bjd/ljac130
Bissonnette R, Warren RB, Pinter A, Agner T, Gooderham M, Schuttelaar ML, et al. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials. Lancet 2024; 404: 461–473. DOI: https://doi.org/10.1093/bjd/ljae266.032
McCluskey D, Benzian-Olsson N, Mahil SK, Hassi NK, Wohnhaas CT, Burden AD, et al. Single-cell analysis implicates T(H)17-to-T(H)2 cell plasticity in the pathogenesis of palmoplantar pustulosis. J Allergy Clin Immunol 2022; 150: 882–893. DOI: https://doi.org/10.1016/j.jaci.2022.04.027
Published
How to Cite
License
Copyright (c) 2025 Nikolai Loft, Claus Zachariae, Mette Gyldenløve, Farzad Alinaghi, Diljit Kaur-Knudsen, Lone Skov
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
